[[Hyponatremia Notes]]

OVERVIEW

**General** (_NEJM_ 2015;372:55 & 373:1350)

•Disorders of serum sodium are generally due to Δs in _total body water_, not sodium

•Hyper- or hypo-osmolality → rapid water shifts → Δs in brain cell volume → Δ MS, seizures

**Key hormones**

•**Antidiuretic hormone (ADH):** primary hormone that regulates _sodium concentration_

_Stimuli:_ hyperosmolality (290–295 mOsm), ↓↓ effective arterial volume, angiotensin II

_Action:_ insertion of aquaporin-2 channels in principal cells → passive water reabsorption

**urine osmolality** is an indirect functional assay of the ADH-renal axis

Uosm range: 50 mOsm/L (no ADH) to 1200 mOsm/L (maximal ADH)

•**Aldosterone:** primary hormone that regulates _total body sodium_ (and ∴ volume)

_Stimuli for secretion:_ hypovolemia (via renin and angiotensin II), hyperkalemia

_Action:_ iso-osmotic principal cell reabsorption of Na via epithelial Na channel (ENaC) in exchange for K+ or H+

HYPONATREMIA

**Pathophysiology** (_JASN_ 2008;19:1076; _NEJM_ 2015;372:1349)

•Free water clearance (CH²O) = solute (intake) excretion/Uosm normal dietary solute load ~750 mOsm/d, minimum Uosm = 50 mOsm/L → excrete ~15 L

•**Excess H****2****O relative to Na**, usually due to ↑ **ADH**

•↑ ADH may be _appropriate_ (eg, hypovolemia or hypervolemia with ↓ EAV)

•↑ ADH may be _inappropriate_ (SIADH)

•Rarely, ↓ ADH (appropriately suppressed), but kidneys unable to maintain nl [Na]serum

↑ _H2O intake (1_° _polydipsia):_ ingestion of massive quantities (usually >15 L/d) of free H2O overwhelms diluting ability of kidney → H2O retention

↓ solute intake (“tea & toast” & beer potomania_):_ ↓↓ daily solute load → insufficient solute to excrete H2O intake (eg, if only 250 mOsm/d, minimum Uosm = 50 mOsm/L → excrete in ~5 L; if H2O ingestion exceeds this amount → H2O retention)

**Workup** (_JASN_ 2012;23:1140 & 2017;28:1340; _Crit Care_ 2013;17:206; _NEJM_ 2015;372:55)

•**History:** (1) acute vs. chronic (>48 h); (2) sx severity; (3) risk for neuro complications (alcoholism, malnourished, cirrhosis, older females on thiazides, hypoxia, hypoK)

•Measure **plasma osmolality**

_Hypotonic (Posm_ <_280)_ most common scenario; true excess of free H2O relative to Na

_Isotonic (Posm 280_–_295):_ rare lab artifact from hyperlipidemia or hyperproteinemia

_Hypertonic (Posm_ >_295):_ excess of another effective osmole (eg, glucose, mannitol) that draws H2O intravascularly; for each 100 mg/dL ↑ glc >100 mg/dL → ↓ [Na] by ~2 mEq/L

•For hypotonic hyponatremia, ✔ **volume status** (JVP, skin turgor, dry axilla, mucous membranes, edema, ascites), effusions, vital signs, orthostatics, BUN/Cr, FEUricAcid, UNa

•Measure **U****osm**, although useful for dx in limited circumstances, b/c almost always >300

Uosm <100 in ↑ H2O intake (1o polydipsia) or ↓ solute intake (beer potomania, “tea & toast”)

Uosm >300 does not mean SIADH; must determine if ↑ ADH appropriate or inappropriate

however, Uosm can be important when deciding on _treatment_ (see below)

•If euvolemic and ↑ Uosm, evaluate for glucocorticoid insufficiency and hypothyroidism

•If available, consider FEUricAcid as >12% suggests SIADH (_J Clinc Endo_ 2008;93:2991)

![](https://i.imgur.com/NhYnvxg.png)

**Hypovolemic hypotonic hyponatremia** (ie, ↓↓ total body Na, ↓ TBW)

•**Renal losses** (UNa >20 mEq/L, FENa >1%): diuretics (esp. thiazides, because loop diuretics

↓ tonicity of medullary interstitium, Δ for H2O absorption, & ∴ urine concentrating ability), salt-wasting nephropathy, cerebral salt wasting, mineralocorticoid deficiency

•**Extrarenal losses** (UNa <10 mEq/L, UCl <10 mEq/L if alkalemia, FENa <1%): hemorrhage, GI loss (diarrhea or vomiting), third-spacing (pancreatitis), ↓ PO intake, insensible losses

**Euvolemic hypotonic hyponatremia** (ie, ↑ TBW relative to total body Na)

•**SIADH** (euvolemia or mild hypervolemia, typically **inapprop Uosm** >**100,** UNa >20 mEq/L)

**Malignancy:** lung (SCLC), brain, GI, GU, lymphoma, leukemia, thymoma, mesothelioma

**Pulmonary:** pneumonia, TB, aspergillosis, asthma, COPD, PTX, mechanical ventilation

**Intracranial:** trauma, stroke, SAH, seizure, infxn, hydrocephalus, Guillain-Barré

**Drugs:** antipsychotics, antidepress. (SSRI, TCA, MAOi), haloperidol, chemo (vincristine, cisplatin), AVP, MDMA, NSAIDs, opiates, amiodarone (_Am J Kidney Dis_ 2008;52:144)

**Miscellaneous:** pain, nausea, postoperative state

•**Endocrinopathies:** ↑ ADH activity seen in _glucocorticoid deficiency_ (co-secretion of ADH & CRH) and _severe hypothyroidism/myxedema coma_ (↓ CO/SVR → ADH release & ↓ GFR)

•**Psychogenic polydipsia** (Uosm <100, ↓ FEUric Acid): usually intake >15 L/d

•**Low solute** (↓ UNa, ↓ Uosm) “tea & toast”; beer potomania

•Reset osmostat: chronic malnutrition (↓ intracellular osmoles) or pregnancy (hormonal

effects) → ADH physiology reset to regulate a lower [Na]serum

**Hypervolemic hypotonic hyponatremia** (ie, ↑ total body Na, ↑ ↑ TBW)

•↓ EAV → ↑ RAAS → ↑ aldosterone & ↑ adrenergic tone → ↑↑ ADH (_Am J Med_ 2013;126:S1)

•**CHF** (↓ CO & renal venous congestion → ↓ EAV; UNa <10 mEq/L, FENa <1%)

•**Cirrhosis** (splanchnic arterial vasodilation + ascites → ↓ EAV; UNa <10 mEq/L, FENa <1%)

•**Nephrotic syndrome** (hypoalbuminemia → edema → ↓ EAV; UNa <10 mEq/L, FENa <1%)

•**Advanced renal failure** (diminished ability to excrete free H2O; UNa >20 mEq/L)

**Treatment** (_NEJM_ 2015;372:55; _JASN_ 2017;28:1340; _CJASN_ 2018;13:641 & 984)

•**Approach:** depends on _volume status_, _acuity_ of hyponatremia, and if _symptomatic_

Acute sx: _initial_ rapid correction of [Na]serum (2 mEq/L/h for the first 2–3 h) until sx resolve

Asx or chronic symptomatic: correct [Na]serum at rate of ≤0.5 mEq/L/h

Rate ↑ Na _should not exceed 6_ (chronic) to _8_ (acute) mEq/L/d to avoid central pontine myelinolysis/osmotic demyelination (CPM/ODS: paraplegia, dysarthria, dysphagia)

If severe (<120) or neuro sx: consider 3% NaCl. dDAVP 1-2 µg q8h in consultation with nephrology (to prevent rapid overcorrection) (_AJKD_ 2013;61:571; _CJASN_ 2018; 13:641)

•**Frequent lab draws** and **IVF rate adjustments** are cornerstones of treatment

•**Rapid correction:** can lead to CPM/ODS (esp if chronic or Na <120 mEq/L). Should be emergently reversed w/ dDAVP ± D5W; partial neuro recovery possible (_CJASN_ 2014;9:229).

•**Effect of IV fluids** ([http://www.medcalc.com/sodium.html](http://www.medcalc.com/sodium.html))

![](https://i.imgur.com/2k4vcLT.png)

![](https://i.imgur.com/ZNi1fjY.png)

_However_, above assumes infusate retained _without output of Na/H2_O; adjust for UOP.  
If Pt euvolemic (eg, SIADH), infused Na will be excreted: for 1 L NS (154 mEq Na or 308 mOsm solute in 1 L H2O); in SIADH with Uosm = 616 → 308 mOsm solute excreted in 0.5 L H2O → net gain 0.5 L H2O → ↓ [Na]serum. ∴ NS _worsens_ Na if Uosm > infusateosm.

•**Hypovolemic hyponatremia:** volume repletion with isotonic 0.9% saline at a **slow rate**. Once volume replete → stimulus for ADH removed (w/ very short ADH t½) → kidneys excrete free H2O → serum Na will correct rapidly (D5W ± ddAVP if overcorrection)

•**SIADH** (_NEJM_ 2007;356:2064; _AJKD_ 2015;65:435): **fluid restrict** + treat underlying cause

**hypertonic saline** (± loop diuretic) if sx or Na fails to ↑ w/ fluid restriction 1 L hypertonic saline (3% NaCl) will raise [Na]serum by ~10 mEq (see above) ~50 mL/h will ↑ [Na] by ~0.5 mEq/L/h; 100–200 mL/h will ↑ [Na] by ~1–2 mEq/L/h formula only provides estimate; ∴ recheck serum Na frequently (at least q2h)

NaCl tabs if chronic and no CHF. Consider urea 0.25-0.5g/kg/d (_Nephrol Dial Trans_ 2014;29:ii1)

aquaresis: vaptans (vasopressin receptor antag) for refractory SIADH (_NEJM_ 2015;372:23)

demeclocycline: causes nephrogenic DI, ↓ Uosm (rarely used)

•**Hypervolemic hyponatremia:** free water restrict (1st line), diurese w/ loop diuretics (avoid thiazides) & ↑ EAV (vasodilators to ↑ CO in CHF, colloid infusion in cirrhosis)

vaptans sometimes used; however, no mortality benefit, hypoNa recurs after stopping drug, high risk of overcorrection, contraindicated in cirrhosis (_NEJM_ 2015;372:2207)

[[HYPERNATREMIA]]
[[POLYURIA]]